Alvotech Sees AbbVie’s Humira Trade Secrets Case Thrown Out In US
AbbVie Had Accused Alvotech Employee Of Stealing ‘Useful’ Information
One part of a multi-pronged attack launched by AbbVie against Alvotech over the company’s proposed Humira (adalimumab) biosimilar has fallen, with a US district court stating that AbbVie’s US trade secrets lawsuit should be dismissed because it lacks a form of jurisdiction.
